Q3 2026 13F filing
Updated 6 days ago58 disclosed positions worth $887.7M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E ETON PHARMACEUTICALS INC | $125.6M | 2.44M | 14.15% | — |
| 2 | I DISC MEDICINE INC | $71.7M | 1.09M | 8.07% | — |
| 3 | H HARROW INC | $64.8M | 2.10M | 7.30% | — |
| 4 | L LIQUIDIA CORPORATION | $63.8M | 2.11M | 7.19% | — |
| 5 | U UROGEN PHARMA LTD | $58.5M | 1.44M | 6.59% | — |
| 6 | S SOL-GEL TECHNOLOGIES LTD | $41.2M | 555.0K | 4.64% | — |
| 7 | M MEIRAGTX HLDGS PLC | $39.6M | 3.60M | 4.46% | — |
| 8 | T TG THERAPEUTICS INC | $31.1M | 557.0K | 3.50% | — |
| 9 | A ALPHA COGNITION INC | $29.7M | 3.30M | 3.35% | — |
| 10 | ? N/A IMMIX BIOPHARMA INC | $29.4M | 2.83M | 3.31% | — |
| 11 | C CRESCENT BIOPHARMA INC. | $24M | 1.65M | 2.71% | — |
| 12 | V VERASTEM INC | $22.2M | 2.75M | 2.50% | — |
| 13 | R REVOLUTION MEDICINES INC | $20.5M | 100.0K | 2.31% | — |
| 14 | Q REPLIMUNE GROUP INC | $18.3M | 1.38M | 2.07% | — |
| 15 | S STOKE THERAPEUTICS INC | $18M | 692.2K | 2.03% | — |
| 16 | S SUMMIT THERAPEUTICS INC | $17.8M | 1.05M | 2.00% | — |
| 17 | R REZOLUTE INC | $16.9M | 4.09M | 1.91% | — |
| 18 | B BIOHAVEN LTD | $15.9M | 1.19M | 1.79% | — |
| 19 | P PROTAGONIST THERAPEUTICS INC | $14.1M | 100.0K | 1.59% | — |
| 20 | M MONTE ROSA THERAPEUTICS INC | $12.3M | 1.03M | 1.39% | — |
| 21 | R RHYTHM PHARMACEUTICALS INC | $11.7M | 122.5K | 1.31% | — |
| 22 | Q Q32 BIO INC | $9.3M | 1.12M | 1.04% | — |
| 23 | H HARMONY BIOSCIENCES HLDGS IN | $9M | 230.0K | 1.02% | — |
| 24 | E EDITAS MEDICINE INC | $9M | 3.49M | 1.01% | — |
| 25 | A ALUMIS INC | $7.4M | 1.00M | 0.83% | — |
| 26 | E EDGEWISE THERAPEUTICS INC | $7.1M | 175.0K | 0.80% | — |
| 27 | ? N/A GRACE THERAPEUTICS INC | $6M | 2.80M | 0.68% | — |
| 28 | S SYNDAX PHARMACEUTICALS INC | $5.9M | 315.2K | 0.67% | — |
| 29 | G GOSSAMER BIO INC | $5.1M | 427.0K | 0.57% | — |
| 30 | A ADC THERAPEUTICS SA | $5M | 4.07M | 0.56% | — |
| 31 | J JASPER THERAPEUTICS INC | $4.9M | 280.8K | 0.55% | — |
| 32 | F 4D MOLECULAR THERAPEUTICS IN | $4.8M | 334.4K | 0.54% | — |
| 33 | I INHIBRX BIOSCIENCES INC | $4.6M | 45.5K | 0.51% | — |
| 34 | C CABALETTA BIO INC | $4.5M | 2.32M | 0.50% | — |
| 35 | T TREVI THERAPEUTICS INC | $4.4M | 310.0K | 0.50% | — |
| 36 | ? N/A VOYAGER THERAPEUTICS INC | $4.4M | 1.63M | 0.49% | — |
| 37 | ? N/A ZENTALIS PHARMACEUTICALS INC | $3.9M | 1.41M | 0.44% | — |
| 38 | O OCULAR THERAPEUTIX INC | $3.9M | 506.4K | 0.44% | — |
| 39 | R RELMADA THERAPEUTICS INC | $3.8M | 1.00M | 0.42% | — |
| 40 | A ANNEXON INC | $3.7M | 875.0K | 0.42% | — |
| 41 | I OPUS GENETICS INC | $3.6M | 750.0K | 0.41% | — |
| 42 | C CODEXIS INC | $3.6M | 2.59M | 0.41% | — |
| 43 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $3.3M | 175.0K | 0.37% | — |
| 44 | L LYELL IMMUNOPHARMA INC | $2.9M | 291.4K | 0.32% | — |
| 45 | R ROCKET PHARMACEUTICALS INC | $2.6M | 1.00M | 0.30% | — |
| 46 | B BIODESIX INC | $2.6M | 87.0K | 0.29% | — |
| 47 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $2.6M | 630.0K | 0.29% | — |
| 48 | O OKYO PHARMA LTD | $2.1M | 1.62M | 0.24% | — |
| 49 | J JADE BIOSCIENCES INC | $2M | 140.5K | 0.22% | — |
| 50 | E ENANTA PHARMACEUTICALS INC | $1.6M | 125.0K | 0.19% | — |